HRP20100239T1 - Poboljšana šema sinteze za lakozamid - Google Patents
Poboljšana šema sinteze za lakozamid Download PDFInfo
- Publication number
- HRP20100239T1 HRP20100239T1 HR20100239T HRP20100239T HRP20100239T1 HR P20100239 T1 HRP20100239 T1 HR P20100239T1 HR 20100239 T HR20100239 T HR 20100239T HR P20100239 T HRP20100239 T HR P20100239T HR P20100239 T1 HRP20100239 T1 HR P20100239T1
- Authority
- HR
- Croatia
- Prior art keywords
- compound
- substituted
- unsubstituted
- formula
- methoxypropionamide
- Prior art date
Links
- VPPJLAIAVCUEMN-GFCCVEGCSA-N lacosamide Chemical compound COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1 VPPJLAIAVCUEMN-GFCCVEGCSA-N 0.000 title claims abstract 13
- 229960002623 lacosamide Drugs 0.000 title claims abstract 9
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract 33
- 150000001875 compounds Chemical class 0.000 claims abstract 15
- 238000007069 methylation reaction Methods 0.000 claims abstract 8
- 238000006243 chemical reaction Methods 0.000 claims abstract 6
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims abstract 5
- 239000012071 phase Substances 0.000 claims 10
- 230000007704 transition Effects 0.000 claims 10
- 229910052757 nitrogen Inorganic materials 0.000 claims 9
- 125000005842 heteroatom Chemical group 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 229910052717 sulfur Inorganic materials 0.000 claims 8
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- WPLANNRKFDHEKD-SNVBAGLBSA-N Descarbonyl-lacosamide Chemical compound COC[C@@H](N)C(=O)NCC1=CC=CC=C1 WPLANNRKFDHEKD-SNVBAGLBSA-N 0.000 claims 5
- 239000007864 aqueous solution Substances 0.000 claims 5
- 150000002900 organolithium compounds Chemical class 0.000 claims 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 claims 4
- 239000003054 catalyst Substances 0.000 claims 4
- 238000006555 catalytic reaction Methods 0.000 claims 4
- -1 hexafluoroantimonate Chemical group 0.000 claims 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 239000012022 methylating agents Substances 0.000 claims 3
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims 2
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical group CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 2
- 239000012190 activator Substances 0.000 claims 2
- 239000008346 aqueous phase Substances 0.000 claims 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 230000011987 methylation Effects 0.000 claims 2
- 238000005580 one pot reaction Methods 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- FHOAKXBXYSJBGX-RXMQYKEDSA-N (2r)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](CO)C(O)=O FHOAKXBXYSJBGX-RXMQYKEDSA-N 0.000 claims 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims 1
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical group CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 claims 1
- 229930195711 D-Serine Natural products 0.000 claims 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 229910006069 SO3H Inorganic materials 0.000 claims 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical group [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims 1
- 238000006640 acetylation reaction Methods 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001718 carbodiimides Chemical class 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 150000004820 halides Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Chemical group SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical group OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 235000010755 mineral Nutrition 0.000 claims 1
- 239000012074 organic phase Substances 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical group OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims 1
- 235000015497 potassium bicarbonate Nutrition 0.000 claims 1
- 239000011736 potassium bicarbonate Substances 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 235000011181 potassium carbonates Nutrition 0.000 claims 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 claims 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical group [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical group CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
- 125000003944 tolyl group Chemical group 0.000 claims 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical group [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 1
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
- C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
- C07C273/1854—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04023556A EP1642889A1 (en) | 2004-10-02 | 2004-10-02 | Improved synthesis scheme for lacosamide |
| PCT/EP2005/010603 WO2006037574A1 (en) | 2004-10-02 | 2005-09-30 | Improved synthesis scheme for lacosamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100239T1 true HRP20100239T1 (hr) | 2010-06-30 |
Family
ID=34926827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100239T HRP20100239T1 (hr) | 2004-10-02 | 2010-04-26 | Poboljšana šema sinteze za lakozamid |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7884134B2 (he) |
| EP (2) | EP1642889A1 (he) |
| JP (1) | JP5128281B2 (he) |
| KR (1) | KR101246169B1 (he) |
| CN (2) | CN1989102B (he) |
| AT (1) | ATE457975T1 (he) |
| AU (1) | AU2005291456B2 (he) |
| BR (1) | BRPI0516735B8 (he) |
| CA (1) | CA2570598C (he) |
| CY (1) | CY1109994T1 (he) |
| DE (1) | DE602005019437D1 (he) |
| DK (1) | DK1799635T3 (he) |
| EA (1) | EA012588B1 (he) |
| ES (1) | ES2341470T3 (he) |
| HR (1) | HRP20100239T1 (he) |
| IL (1) | IL180479A (he) |
| MX (1) | MX2007001253A (he) |
| NO (1) | NO336765B1 (he) |
| NZ (1) | NZ552076A (he) |
| PL (1) | PL1799635T3 (he) |
| SI (1) | SI1799635T1 (he) |
| UA (1) | UA95600C2 (he) |
| WO (1) | WO2006037574A1 (he) |
| ZA (1) | ZA200610000B (he) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2262567T3 (es) | 2001-03-20 | 2006-12-01 | Schwarz Pharma Ag | Nuevo uso de una clase peptidica de compuesto para tratamiento del dolor inflamatorio no neuropatico. |
| ES2185606T3 (es) * | 2001-03-21 | 2003-05-01 | Sanol Arznei Schwarz Gmbh | Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma. |
| JP4664924B2 (ja) * | 2003-12-02 | 2011-04-06 | ウーツェーベー ファルマ ゲーエムベーハー | 中枢神経因性疼痛の治療のためのペプチド化合物の新規使用 |
| US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
| EP1579858A1 (en) * | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
| US20100256179A1 (en) * | 2004-03-26 | 2010-10-07 | Ucb Pharma Gmbh | Combination therapy for pain in painful diabetic neuropathy |
| US8008351B2 (en) * | 2004-04-16 | 2011-08-30 | Ucb Pharma Gmbh | Methods for prophylaxis or treatment of conditions associated with cortical spreading depression |
| EP1604655A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in trigeminal neuralgia |
| NZ552651A (en) * | 2004-08-27 | 2010-07-30 | Sanol Arznei Schwarz Gmbh | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| EP1642889A1 (en) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Improved synthesis scheme for lacosamide |
| US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
| US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
| EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
| WO2007059805A1 (de) | 2005-11-24 | 2007-05-31 | Kronospan Technical Company Ltd. | BESCHICHTUNGSANLAGE MIT FLIEßFÄHIGEM BESCHICHTUNGSMATERIAL FÜR GLATTE ODER STRUKTURIERTE OBERFLÄCHEN |
| EP1873527A1 (en) * | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
| EP2037965B1 (en) | 2006-06-15 | 2017-08-30 | UCB Pharma GmbH | Pharmaceutical composition with synergistic anticonvulsant effect |
| CN101466390B (zh) * | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
| WO2009053070A1 (en) * | 2007-10-23 | 2009-04-30 | Schwarz Pharma Ag | Compounds for treating demyelination conditions |
| US8093426B2 (en) | 2007-12-04 | 2012-01-10 | Ranbaxy Laboratories Limited | Intermediate compounds and their use in preparation of lacosamide |
| WO2009146325A1 (en) | 2008-05-28 | 2009-12-03 | Pliva Hrvatska D.O.O. | Polymorphic and amorphous forms of lacosamide and amorphous compositions |
| ES2408208T3 (es) * | 2008-11-07 | 2013-06-19 | Ucb Pharma Gmbh | Nuevo procedimiento para preparar derivados de aminoácidos. |
| DE102008059155A1 (de) | 2008-11-27 | 2010-06-02 | Ratiopharm Gmbh | Trockenverarbeitung und neue Formen von Lacosamid |
| CN101591300B (zh) * | 2009-02-19 | 2011-05-04 | 成都伊诺达博医药科技有限公司 | 合成拉考沙胺的新方法 |
| WO2010107993A2 (en) | 2009-03-18 | 2010-09-23 | Pliva Hrvatska D.O.O. | Process for preparing (r)-7v-benzyl-2- (benyloxycarbonylamino)-s-methoxypropionamide |
| US8440861B2 (en) | 2009-08-06 | 2013-05-14 | Medichem, S.A. | Solid forms of an N-(phenylmethyl)propanamide derivative and processes of preparation |
| CN102020589B (zh) * | 2009-09-19 | 2013-11-06 | 浙江九洲药业股份有限公司 | 一种氨基甲酸叔丁酯衍生物及其制备方法和应用 |
| WO2011039781A1 (en) * | 2009-09-25 | 2011-04-07 | Cadila Healthcare Limited | Processes for the preparation of lacosamide and intermediates thereof |
| WO2011061610A2 (en) | 2009-11-19 | 2011-05-26 | Ranbaxy Laboratories Limited | Processes for preparation of polymorphic forms of lacosamide |
| US8853453B2 (en) | 2010-01-29 | 2014-10-07 | Ranbaxy Laboratories Limited | Processes for reducing impurities in lacosamide |
| IT1398044B1 (it) | 2010-01-29 | 2013-02-07 | Archimica Srl | Processo per la preparazione della lacosamide |
| CN102146048B (zh) * | 2010-02-06 | 2013-11-13 | 浙江九洲药业股份有限公司 | 拉科酰胺中间体化合物及其制备方法和应用 |
| US8829226B2 (en) * | 2010-02-06 | 2014-09-09 | Zhejiang Jiuzhou Pharmaceutical Co., Ltd | Lacosamide intermediate compound, preparation method thereof and use thereof |
| US8759582B2 (en) | 2010-02-08 | 2014-06-24 | Natco Pharma Limited | Process for the preparation of lacosamide |
| WO2011099033A1 (en) * | 2010-02-09 | 2011-08-18 | Msn Laboratories Limited | Process for preparing (r)-2-acetamido-n-benzyl-3-methoxy-propionamide |
| WO2011130615A2 (en) * | 2010-04-15 | 2011-10-20 | Dr. Reddy's Laboratories Ltd. | Preparation of lacosamide |
| US20130123537A1 (en) * | 2010-05-17 | 2013-05-16 | K a s s Narayan Garimella | Process for the preparation of lacosamide |
| WO2011158194A1 (en) | 2010-06-15 | 2011-12-22 | Medichem, S.A. | Enzymatic resolution of racemic (2r,s)-2-(acetylamino)-3-methoxy-n-(phenylmethyl)propanamide |
| EP2399901A1 (en) | 2010-06-23 | 2011-12-28 | Archimica GmbH | Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide |
| US20130102811A1 (en) * | 2010-07-02 | 2013-04-25 | Sun Pharmaceutical Industries Ltd | Process for the preparation of lacosamide |
| US8957252B2 (en) | 2010-07-27 | 2015-02-17 | Indoco Remedies Limited | Process for preparation of lacosamide and some N-benzyl-propanamide intermediate derivatives |
| EP2621893A1 (en) | 2010-10-01 | 2013-08-07 | UCB Pharma GmbH | Process for the preparation of amino acid derivatives |
| EP2444390B1 (en) | 2010-10-19 | 2017-02-01 | Euticals GmbH | Process for producing Lacosamide |
| EP2487152A1 (en) | 2010-11-17 | 2012-08-15 | UCB Pharma GmbH | Process for the preparation of Lacosamide including resolution of O-methyl-DL-serine |
| GB201020026D0 (en) | 2010-11-25 | 2011-01-12 | Cambrex Karlskoga Ab | New process |
| EP2468261A1 (en) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
| CN102320993B (zh) * | 2011-07-13 | 2013-11-27 | 石家庄四药有限公司 | 一种制备(r)-2-叔丁氧羰基氨基-3-甲氧基丙酸的方法 |
| WO2013024383A1 (en) * | 2011-08-12 | 2013-02-21 | Alembic Pharmaceuticals Limited | An improved process for the preparation of lacosamide |
| MX337610B (es) | 2011-08-29 | 2016-03-10 | Signa S A De C V | Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma. |
| WO2013072933A2 (en) * | 2011-10-03 | 2013-05-23 | Glenmark Generics Limited | Process for preparation of 2-acetamido-n-benzyl-3-methoxypropionamide |
| EP2776388A4 (en) | 2011-11-10 | 2015-07-08 | Davuluri Ramamohan Rao | AN INEDIC PROCESS FOR THE PREPARATION OF (R) -N-BENZYL-2-ACETAMIDO-3-METHOXYPROPIONAMIDE |
| JP2014533292A (ja) | 2011-11-15 | 2014-12-11 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Ｎ−置換された２−（アセチルアミノ）−ｎ’−ベンジル−３−メトキシプロパンアミドの製造方法 |
| US8748660B2 (en) | 2012-07-09 | 2014-06-10 | Council Of Scientific & Industrial Research | Process for the synthesis of antiepileptic drug lacosamide |
| CN102816083B (zh) * | 2012-07-30 | 2015-09-23 | 永光制药有限公司 | 拉科酰胺的制备方法 |
| GB201219627D0 (en) | 2012-11-01 | 2012-12-12 | Cambrex Karlskoga Ab | New process |
| WO2014155264A1 (en) | 2013-03-25 | 2014-10-02 | Jubilant Life Sciences Limited | Process for the preparation of lacosamide using novel intermediates |
| CN103342655A (zh) * | 2013-07-02 | 2013-10-09 | 扬州大学 | 取代乙二酮双苯胺希夫碱合成取代酰胺的新方法 |
| KR101578979B1 (ko) * | 2013-11-08 | 2015-12-18 | 에스티팜 주식회사 | 라코사마이드의 제조방법 |
| MX2017002609A (es) | 2014-08-28 | 2017-05-30 | Davuluri Ramamohan Rao | Procedimiento mejorado para la preparacion de lacosamida y su intermediario novedoso. |
| JPWO2016039393A1 (ja) * | 2014-09-10 | 2017-06-22 | 株式会社エーピーアイ コーポレーション | アミノ酸誘導体の製造方法 |
| CN104761465B (zh) * | 2015-03-18 | 2017-05-31 | 四川同晟生物医药有限公司 | 一种拉科酰胺的制备方法 |
| CN106699605B (zh) * | 2015-07-21 | 2019-08-20 | 上海医药集团股份有限公司 | 一种拉科酰胺中间体的甲基化方法 |
| CN106699595B (zh) * | 2015-07-21 | 2019-04-12 | 上海医药集团股份有限公司 | 一种拉科酰胺制备方法 |
| IN2015CH05001A (he) | 2015-09-18 | 2015-10-16 | Divis Lab Ltd | |
| US10975117B2 (en) | 2015-11-13 | 2021-04-13 | Api Corporation | Method for producing lacosamide and intermediate thereof |
| MX2018008021A (es) | 2015-12-30 | 2018-11-09 | Adamas Pharmaceuticals Inc | Metodos y composiciones para el tratamiento de trastornos relacionados con convulsiones. |
| US9718765B1 (en) | 2016-06-21 | 2017-08-01 | Sci Pharmtech, Inc. | Process for preparation of optically pure N-substituted-3-methoxypropionic acid derivatives |
| US10414720B2 (en) * | 2016-09-28 | 2019-09-17 | Unichem Laboratories Ltd. | Process for the preparation of lacosamide |
| CN106811492B (zh) * | 2017-01-18 | 2019-11-01 | 长兴制药股份有限公司 | 一种拉科酰胺的制备方法 |
| KR20190081386A (ko) | 2017-12-29 | 2019-07-09 | 강원대학교산학협력단 | 루핀아마이드를 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
| KR20190081385A (ko) | 2017-12-29 | 2019-07-09 | 강원대학교산학협력단 | 옥스카바제핀을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
| CN110320291A (zh) * | 2019-06-21 | 2019-10-11 | 山东省药学科学院 | 一种hplc法定量检测拉考沙胺注射液含量的方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5129456A (en) * | 1974-08-30 | 1976-03-12 | Tanabe Seiyaku Co | Kogakukatsusei oo benjiruserinjudotai no seiho |
| JPS62132849A (ja) * | 1985-12-04 | 1987-06-16 | Toray Ind Inc | Ｄ−またはＬ−Ｎ−ｔ−ブトキシカルボニル−Ｏ−ベンジルセリンの製造方法 |
| US5585358A (en) * | 1993-07-06 | 1996-12-17 | Yissum Research Development Corporation Of The Hebrew University Of Jerusalem | Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents |
| DE69729392T2 (de) * | 1996-03-15 | 2005-06-02 | Research Corp. Technologies, Inc., Tucson | Krampfhemmende enantiomere Aminosäurederivate |
| US6048899A (en) * | 1997-03-17 | 2000-04-11 | Research Corporation Tech., Inc. | Anticonvulsant enantiomeric amino acid derivatives |
| JP3996671B2 (ja) * | 1997-07-09 | 2007-10-24 | タマ化学工業株式会社 | Ｎ−アルコキシカルボニル化、ｎ−アルケニルオキシカルボニル化またはｎ−アリールアルコキシカルボニル化されたアミノ酸類の製造方法 |
| MXPA03001458A (es) * | 2000-08-17 | 2004-05-04 | Teva Pharma | Derivados de acido valproico para el tratamiento del dolor. |
| ES2262567T3 (es) * | 2001-03-20 | 2006-12-01 | Schwarz Pharma Ag | Nuevo uso de una clase peptidica de compuesto para tratamiento del dolor inflamatorio no neuropatico. |
| ES2185606T3 (es) * | 2001-03-21 | 2003-05-01 | Sanol Arznei Schwarz Gmbh | Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma. |
| WO2004014895A1 (en) * | 2002-08-05 | 2004-02-19 | Eli Lilly And Company | Piperazine substituted aryl benzodiazepines |
| JP4664924B2 (ja) * | 2003-12-02 | 2011-04-06 | ウーツェーベー ファルマ ゲーエムベーハー | 中枢神経因性疼痛の治療のためのペプチド化合物の新規使用 |
| US20060009384A1 (en) * | 2003-12-05 | 2006-01-12 | David Rudd | Novel use of peptide compounds for treating status epilepticus or related conditions |
| EP1579858A1 (en) * | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
| US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
| US20100256179A1 (en) * | 2004-03-26 | 2010-10-07 | Ucb Pharma Gmbh | Combination therapy for pain in painful diabetic neuropathy |
| US8008351B2 (en) * | 2004-04-16 | 2011-08-30 | Ucb Pharma Gmbh | Methods for prophylaxis or treatment of conditions associated with cortical spreading depression |
| EP1604654A1 (en) * | 2004-05-18 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating dyskinesia |
| EP1604655A1 (en) * | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in trigeminal neuralgia |
| EP1604656A1 (en) * | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS) |
| US7427601B2 (en) * | 2004-06-24 | 2008-09-23 | Schwarz Pharma Ag | Method for treating tremor |
| NZ552651A (en) * | 2004-08-27 | 2010-07-30 | Sanol Arznei Schwarz Gmbh | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| EP1642889A1 (en) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Improved synthesis scheme for lacosamide |
| US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
| US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
| EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
| US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
| EP1873527A1 (en) * | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
| CN101466390B (zh) * | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
| EP2037965B1 (en) * | 2006-06-15 | 2017-08-30 | UCB Pharma GmbH | Pharmaceutical composition with synergistic anticonvulsant effect |
| WO2009053070A1 (en) * | 2007-10-23 | 2009-04-30 | Schwarz Pharma Ag | Compounds for treating demyelination conditions |
| EP2468261A1 (en) * | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
| AU2011335415B2 (en) * | 2010-12-02 | 2016-05-19 | Ucb Pharma Gmbh | Once daily formulation of lacosamide |
-
2004
- 2004-10-02 EP EP04023556A patent/EP1642889A1/en not_active Withdrawn
-
2005
- 2005-09-30 CN CN2005800241755A patent/CN1989102B/zh not_active Expired - Fee Related
- 2005-09-30 AU AU2005291456A patent/AU2005291456B2/en not_active Ceased
- 2005-09-30 ES ES05794396T patent/ES2341470T3/es active Active
- 2005-09-30 BR BRPI0516735A patent/BRPI0516735B8/pt not_active IP Right Cessation
- 2005-09-30 MX MX2007001253A patent/MX2007001253A/es active IP Right Grant
- 2005-09-30 DE DE602005019437T patent/DE602005019437D1/de active Active
- 2005-09-30 NZ NZ552076A patent/NZ552076A/en not_active IP Right Cessation
- 2005-09-30 EA EA200700746A patent/EA012588B1/ru not_active IP Right Cessation
- 2005-09-30 WO PCT/EP2005/010603 patent/WO2006037574A1/en active Application Filing
- 2005-09-30 PL PL05794396T patent/PL1799635T3/pl unknown
- 2005-09-30 AT AT05794396T patent/ATE457975T1/de active
- 2005-09-30 CA CA2570598A patent/CA2570598C/en not_active Expired - Fee Related
- 2005-09-30 KR KR1020077002247A patent/KR101246169B1/ko active IP Right Grant
- 2005-09-30 DK DK05794396.1T patent/DK1799635T3/da active
- 2005-09-30 CN CN2010101835217A patent/CN101928230B/zh not_active Expired - Fee Related
- 2005-09-30 JP JP2007533955A patent/JP5128281B2/ja active Active
- 2005-09-30 US US11/664,316 patent/US7884134B2/en not_active Expired - Fee Related
- 2005-09-30 UA UAA200704328A patent/UA95600C2/ru unknown
- 2005-09-30 SI SI200530992T patent/SI1799635T1/sl unknown
- 2005-09-30 EP EP05794396A patent/EP1799635B1/en active Active
-
2006
- 2006-11-30 ZA ZA200610000A patent/ZA200610000B/xx unknown
-
2007
- 2007-01-01 IL IL180479A patent/IL180479A/he active IP Right Grant
- 2007-04-30 NO NO20072250A patent/NO336765B1/no not_active IP Right Cessation
-
2010
- 2010-04-26 HR HR20100239T patent/HRP20100239T1/hr unknown
- 2010-04-30 CY CY20101100383T patent/CY1109994T1/el unknown
- 2010-12-07 US US12/961,705 patent/US8809585B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100239T1 (hr) | Poboljšana šema sinteze za lakozamid | |
| KR960703398A (ko) | 피페리딘 유도체 및 그의 제조 방법(Piperidine Derivatives and Process for Their Production) | |
| ES2624675T3 (es) | Nuevo proceso de preparación de la ceftarolina fosamil | |
| Saba et al. | A simple and efficient one-step protocol for the preparation of alkyl-substituted ammonium tetrafluoroborate and hexafluorophosphate salts | |
| CA2889448C (en) | Process for the preparation of cabazitaxel and its intermediates | |
| Bielecki et al. | Lithium-stabilized nucleophilic addition of thiamin to a ketone provides an efficient route to mandelylthiamin, a critical pre-decarboxylation intermediate | |
| ES2312800T3 (es) | Conversion de moleculas de taxano. | |
| JP3822925B2 (ja) | ２’−３’−ジ−ｏ−アシルａｔｐの製造法 | |
| US5486619A (en) | Method of producing DAI from DOPA, using one reaction vessel | |
| JPS63316743A (ja) | 脱アシル化方法 | |
| JP4242937B2 (ja) | １ｈ−１，２，４−トリアゾール誘導体の製造方法 | |
| KR950003300A (ko) | 신규 세팔로스포린계 항생제 및 그의 제조방법 | |
| JPS5824432B2 (ja) | ベンゼンスルホンサンアミドユウドウタイノ セイゾウホウホウ | |
| KR980002027A (ko) | N-[(퀴놀린-2-일)페닐]설폰아미드의 결정 및 이의 제조 방법 | |
| KR20150053362A (ko) | 라코사마이드의 제조방법 | |
| JPS5825661B2 (ja) | Ｎ−アシル−１−アシル−４−グアニジノブチルアミンおよびその酸付加塩 | |
| GB1309375A (en) | Phosphono substituted acylpenicillins | |
| HUP0003768A2 (hu) | Eljárás klór-hangyasav-tioészterek előállítására | |
| RU2003124060A (ru) | Производные индолина и способ их получения | |
| JP3224282B2 (ja) | アミノポリカルボン酸誘導体 | |
| JP3013760B2 (ja) | ４−ヒドロキシ−２−ピロリドンの製法 | |
| JP3161793B2 (ja) | 新規アミノポリカルボン酸誘導体 | |
| BR112020009568A2 (pt) | Método de produção de composto intermediário para síntese de medicamento | |
| WO2024008084A1 (zh) | 一种金鸡纳碱衍生物催化合成手性α-氨基膦酸衍生物的方法 | |
| JPS5933597B2 (ja) | ゴウセイペニシリンノセイゾウホウホウ |